Back to Journals » OncoTargets and Therapy » Volume 13

Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma

Authors Na'ara S, Mukherjee A, Billan S, Gil Z

Received 2 October 2019

Accepted for publication 12 February 2020

Published 16 March 2020 Volume 2020:13 Pages 2289—2298


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Carlos E Vigil

Shorook Na’ara,1,2 Abhishek Mukherjee,3 Salem Billan,2,4 Ziv Gil1,2

1The Laboratory for Applied Cancer Research, Department of Otolaryngology Head and Neck Surgery, Technion-Israel Institute of Technology, Rambam Healthcare Campus, Haifa, Israel; 2The Head and Neck Center, Rambam Healthcare Campus, Clinical Research Institute at Rambam, Rappaport Institute of Medicine and Research, Technion-Israel Institute of Technology, Haifa, Israel; 3Department of Genetics and Developmental Biology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; 4The Oncology Institute, Rambam Health Care Campus, Haifa, Israel

Correspondence: Shorook Na’ara
Department of Otolaryngology, Head and Neck Surgery, Rambam Health Care Campus, Haifa, Israel

Abstract: Sinonasal mucosal melanoma (SNMM) is a rare tumor, comprising less than 10% of sinonasal malignancies. SNMM most frequently occurs in the nasal cavity (70%) and maxillary sinus (14%), typically as black patches. Overall, SNMM harbors a very poor prognosis; 5-year survival is less than 30%. Nasal cavity tumors confer a better prognosis than sinus melanoma. The primary management for SNMM is surgery, when feasible, followed by adjuvant radiotherapy. Recent studies suggest that immunotherapy may confer survival benefit to patients with advanced disease. The multidisciplinary team approach has been shown to optimize treatment, reduce costs, and minimize adverse events, while maximizing the chances for cure.

Keywords: mucosal melanoma, head and neck, multidisciplinary

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]